Cellcept

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
In this study, a suspension of mycophenolate mofetil (MMF) suitable for inhalation was developed using the emulsion template… (More)
  • figure 1
  • table 1
  • figure 3
  • figure 7
Is this relevant?
2010
2010
BACKGROUND Mycophenolate mofetil (MMF, CellCept®) has been utilized as an antirejection agent in transplant recipients and in… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2009
2009
BACKGROUND Mycophenolic acid (MPA) is an immunosuppressant drug commonly used in patients undergoing solid organ transplant… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2007
2007
BACKGROUND Maintenance steroid therapy is associated with significant morbidity and mortality in renal transplant recipients… (More)
Is this relevant?
2007
2007
To determine the safety of a combination of mycophenolate mofetil (Cellcept, MMF) and IFNbeta-1a (Avonex) in relapsing-remitting… (More)
Is this relevant?
2007
2007
Several studies have revealed a decreased incidence of early graft rejection with the use of mycophenate mofetil (MMF). The cost… (More)
Is this relevant?
2006
2006
BACKGROUND Mycophenolic acid (MPA) is an inhibitor of lymphocyte proliferation and is well established as an immunosuppressive… (More)
Is this relevant?
2004
2004
PURPOSE Inosine monophosphate dehydrogenase (IMPDH) inhibitors have been used to induce leukemia blast cell differentiation but… (More)
Is this relevant?
2002
2002
BACKGROUND Previous studies indicate that obesity is a risk factor in renal transplantation. However, these analyses did not… (More)
Is this relevant?
Review
2001
Review
2001
Mycophenolate mofetil (MMF, CellCept), a semisynthetic derivative of mycophenolic acid (MPA) produced by a fungus, is an… (More)
Is this relevant?